What changed: Infant acute lymphoblastic leukaemia (KMT2A-rearranged, under one year)

Every dated change on the records linked to Infant acute lymphoblastic leukaemia (KMT2A-rearranged, under one year), newest first: approvals and regulatory steps on its medicines, trials that reported, guideline versions, milestones, and when this page itself was checked. Dates come from the records; none is inferred. Orientation, not medical advice.